Mainz Biomed NV (Mainz Biomed NV) Total Assets : $15.41 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Mainz Biomed NV Total Assets?

Mainz Biomed NV's Total Assets for the quarter that ended in Dec. 2023 was $15.41 Mil.

During the past 12 months, Mainz Biomed NV's average Total Assets Growth Rate was 169.10% per year. During the past 3 years, the average Total Assets Growth Rate was 147.50% per year.

During the past 5 years, Mainz Biomed NV's highest 3-Year average Total Assets Growth Rate was 147.50%. The lowest was 82.20%. And the median was 114.85%.

Total Assets is connected with ROA %. Mainz Biomed NV's annualized ROA % for the quarter that ended in Dec. 2023 was -124.46%. Total Assets is also linked to Revenue through Asset Turnover. Mainz Biomed NV's Asset Turnover for the quarter that ended in Dec. 2023 was 0.01.

Mainz Biomed NV Total Assets Historical Data

The historical data trend for Mainz Biomed NV's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mainz Biomed NV Total Assets Chart

Mainz Biomed NV Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

0.72

0.67

10.04

20.24

15.41

Mainz Biomed NV Quarterly Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Assets	Get a 7-Day Free Trial								20.24	19.54	19.31	17.91	15.41

Mainz Biomed NV Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Mainz Biomed NV's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	3.249	+	12.16
	=	15.41

Mainz Biomed NV's Total Assets for the quarter that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (Q: Dec. 2023 )	+	Total Liabilities (Q: Dec. 2023 )
	=	3.249	+	12.16
	=	15.41

Mainz Biomed NV (NAS:MYNZ) Total Assets Explanation

Total Assets is connected with ROA %.

Mainz Biomed NV's annualized ROA % for the quarter that ended in Dec. 2023 is

ROA %	=	Net Income (Q: Dec. 2023 )	/	( (Total Assets (Q: Sep. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	-20.732	/	( (17.907	+	15.409)	/ 2 )
	=	-20.732	/	16.658
	=	-124.46 %

Note: The Net Income data used here is four times the quarterly (Dec. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Mainz Biomed NV's Asset Turnover for the quarter that ended in Dec. 2023 is

	Asset Turnover
=	Revenue (Q: Dec. 2023 )	/	( (Total Assets (Q: Sep. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
=	0.215	/	( (17.907	+	15.409)	/ 2 )
=	0.215	/	16.658
=	0.01

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Mainz Biomed NV Total Assets Related Terms

Thank you for viewing the detailed overview of Mainz Biomed NV's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Mainz Biomed NV (Mainz Biomed NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Mainz Biomed NV (NAS:MYNZ) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

4TO:Germany

Address

Robert Koch Strasse 5, Sirius Gutenberg Park, Mainz, RP, DEU, 55129

Website

https://www.mainzbiomed.com

Mainz Biomed NV is engaged in developing molecular genetic diagnostic solutions for life-threatening conditions. Its main product Coloalert is a kit that includes a stool collector and shipping instructions to return the kit through regular mail to their local lab for testing and results.